Esperion Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Okay. Hey, everybody. I'm Marty Auster. I am the lead SMID cap biotech analyst here at Crédit Suisse. You are joining us for the Esperion presentation at the 29th Annual Crédit Suisse Healthcare Conference in the first, and hopefully, the only virtual health care conference we'll be hosting.
I've got Tim Mayleben, CEO; and Rick Bartram, CFO, on the call today. And Tim, Rick, thanks a lot for joining us. Really happy to have you here.
I'll let you kick off and say hi, and you can tell us what it was like trying to launch a drug during the pandemic.
Yes. Thanks, Marty. Thank you for hosting us today and definitely look forward to a nice conversation here this afternoon. I think maybe I'll just start out by saying, no denying, this has been a challenging unprecedented environment. I think we've exhausted superlatives and adjectives to describe what the COVID
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
